Are you Dr. Su?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 61 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6701 Fannin St
Houston, TX 77030Phone+1 832-822-4240Fax+1 832-825-4247- Is this information wrong?
Summary
- Dr. Jack Su, MD is a pediatric hematologist/oncologist in Houston, Texas. He is currently licensed to practice medicine in Texas and California. He is affiliated with Texas Children's Hospital and is an Assistant Professor at Baylor College of Medicine.
Education & Training
- Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 1997 - 2000
- University of California (San Francisco)Residency, Pediatrics, 1994 - 1997
- University of California San Francisco School of MedicineClass of 1994
Certifications & Licensure
- CA State Medical License 1996 - Present
- TX State Medical License 2001 - 2024
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors Start of enrollment: 2005 May 01
- Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma Start of enrollment: 2009 Sep 01
- Vorinostat and Radiation Therapy Followed by Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma Start of enrollment: 2010 Aug 09
Publications & Presentations
PubMed
- Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study.Ayse Bahar Ercan, Melyssa Aronson, Nicholas R Fernandez, Yuan Chang, Adrian Levine, Zhihui Amy Liu, Logine Negm, Melissa Edwards, Vanessa Bianchi, Lucie Stengs, Jiil C...> ;The Lancet. Oncology. 2024 Mar 26
- Phase II study of everolimus for recurrent or progressive pediatric ependymoma.Daniel C Bowers, Veena Rajaram, Matthias A Karajannis, Sharon L Gardner, Jack Meng-Fen Su, Patricia Baxter, Sonia Partap, Laura J Klesse> ;Neuro-Oncology Advances. 2023 Feb 10
- 4 citationsClinical and molecular features of pediatric cancer patients with Lynch syndrome.Sarah Scollon, Mohammad K Eldomery, Jacquelyn Reuther, Frank Y Lin, Samara L Potter, Lauren Desrosiers, Kenneth L McClain, Valeria Smith, Jack Meng-Fen Su, Rajkumar Ve...> ;Pediatric Blood & Cancer. 2022 Nov 1
- Join now to see all
Grant Support
- Study Of Valproic Acid In Pediatric Brain TumorsNational Cancer Institute2006–2009
Hospital Affiliations
- Texas Children's HospitalHouston, Texas